MediPal Holdings Corporation (TYO: 7459)

Market Cap	514.16B
Revenue (ttm)	3.60T
Net Income (ttm)	46.05B
Shares Out	207.95M
EPS (ttm)	219.56
PE Ratio	11.26
Forward PE	14.20
Dividend	60.00 (2.45%)
Ex-Dividend Date	Mar 28, 2025

Volume	553,200
Open	2,467.50
Previous Close	2,451.00
Day's Range	2,453.00 - 2,496.00
52-Week Range	2,170.50 - 2,770.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 1, 2024

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for comp...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1898
• Employees: 13,075
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7459

Financial Performance

In 2023, MediPal Holdings's revenue was 3.56 trillion, an increase of 5.91% compared to the previous year's 3.36 trillion. Earnings were 41.47 billion, an increase of 6.88%.